LZ Therapeutics develops therapeutics for patients at different stages of Parkinson’s disease. It offers neuroprotective/neurorestoritive therapies for early-stage Parkinson’s disease (PD); a combination therapy with levodopa-enhancing and anti-dyskinesia effects designed for mid-stage PD patients; and gene therapies for advanced PD patients. Lazarus will conduct pre-clinical testing of its drug in preparation for an Investigational New Drug filing.
The Ben Franklin Technology Partners of Northeastern Pennsylvania has announced that the World Trade Club of the Lehigh Valley (WTCLV) has become an affiliate of Ben Franklin TechVentures. TechVentures is an award-winning technology incubator/post incubator facility owned and managed by Ben Franklin that is located on the campus of Lehigh University. The Continue Reading ...
Ben Franklin Technology Partners
of Northeastern Pennsylvania
116 Research Drive
Bethlehem, PA 18015
Designed & Developed by Altitude Marketing
The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and
Economic Development and is funded by the Ben Franklin Technology Development Authority.